6 Interesting Facts of Kidney parenchymal hypertension
1. Despite significant improvements in BP control over the past decade, mortality from hypertension remains high.
2. Ambulatory BP monitoring should be considered when diagnosing patients with hypertension.
3. The current blood pressure goal depends on individual patients risk of cardiovascular (CV) events. Patients with a history of CV disease or a 10% risk of atherosclerotic events in the next decade should target a blood pressure below 130/80, all others should target a blood pressure below 140/90.
4. The 2017 ACC/AHA guidelines are largely based on the SPRINT trial which used automated office blood pressure monitoring. There is some concern that using those targets with conventional blood pressure measurements may result in over treatment of blood pressure. If current guidance on BP targets are followed it is important that the BP measurement technique be the same as used in SPRINT.
5. Automated office BP monitoring, a novel way to measure clinic BPs, eliminates the white coat effect.
6. Treatment of hypertension with both an ACE inhibitor and angiotensin receptor blocker (ARB) should be avoided, and a combination of an ACE inhibitor or ARB with spironolactone should only be used with caution.
